thalidomide in the treatment of relapsed multiple myeloma.

NLM AIDSLINE Thalidomide in the treatment of relapsed multiple myeloma. Rajkumar SV; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Kyle
December 30, 2000

Mayo Clin Proc. 2000 Sep;75(9):897-901. Unique Identifier : AIDSLINE OBJECTIVE: To describe the efficacy of therapy with thalidomide, a drug that has antiangiogenic properties, in patients with relapsed multiple myeloma. PATIENTS AND METHODS: We studied 16 patients (median age, 64 years) who received thalidomide for relapsed myeloma at the Mayo Clinic in Rochester, Minn, between November 1998 and August 1999. Treatment consisted of thalidomide given orally at a dose of 200 mg/d for 2 weeks, then increased by 200 mg/d every 2 weeks, up to a maximal dose of 800 mg/d. RESULTS: The stage of myeloma at treatment was Durie-Salmon IIIA in 9 patients (56%) and IIIB in 7 (44%). The median time from myeloma diagnosis to initiation of thalidomide therapy was 32 months. In 4 patients (25%) prior stem cell transplantation had failed, and 14 (88%) had received 2 or more prior chemotherapeutic regimens before institution of thalidomide. All patients were evaluable for response. Four (25%) achieved a partial response to therapy, with a greater than 50% reduction in the serum or urine M protein level. Responses lasted 2, 4+, 8, and 10+ months. Major adverse effects included constipation, sedation, rash, and peripheral neuropathy. CONCLUSION: Thalidomide is an active agent in the treatment of patients with advanced myeloma. JOURNAL ARTICLE Administration, Oral Aged Aged, 80 and over Angiogenesis Inhibitors/PHARMACOLOGY/THERAPEUTIC USE Case Report Disease-Free Survival Female Follow-Up Studies Hematopoietic Stem Cell Transplantation Human Male Middle Age Multiple Myeloma/CLASSIFICATION/DRUG THERAPY/METABOLISM Muscle Proteins/BLOOD/URINE Recurrence Severity of Illness Index Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Thalidomide/PHARMACOLOGY/*THERAPEUTIC USE Treatment Failure

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 SWITZERLAND: Swiss TB Rate Below European Average SOUTH CAROLINA: DHEC Orders North Charleston Clinic to Halt Invasive Procedures CANADA: New Facility Unveiled for Homeless With Hepatitis C FLORIDA: Gospel of Health: Block Party Promotes HIV and AIDS Awareness CALIFORNIA: 2Cents Theatre Group Announces Plans to Benefit HIV/AIDS Organizations with RENT UNITED STATES: HCV Prevalence Higher Among Asian-Americans WALES: HIV Patients Are at Risk of Being Identified Because of New Prescribing System, Warns AM MICHIGAN: Michigan Department of Community Health Encourages Testing for America's Silent Epidemic: Viral Hepatitis Fight Breast Cancer and More at Walk The World, A First of Its Kind Walkathon at The Walt Disney World Resort in Florida When it comes to deadly viruses, what's in a name? UNAIDS reports more than 7 million people now on HIV treatment across Africa––with nearly 1 million added in the last year - while new HIV infections and deaths from AIDS continue to fall CALIFORNIA: $50,000 Prisoner Prescription: Inmates Get Expensive Hepatitis C Treatment ITALY: HIV Is No Barrier to Successful Liver Transplant for Cancer Treatment Viet Nam: South-South learning helps prepare for sustainable provision of AIDS treatment China and Africa Discuss Health Treatment Problems Simpler ARV treatment begins in Eastern Cape AFRICA: Less-Used HIV Treatment for African Children More Effective CANADA: Drug-Resistant Gonorrhea Prompts New Treatment Guidelines in Ont. Less-Used HIV Treatment for African Children More Effective The Next Step in Drug Treatment
Information in this article was accurate in December 30, 2000. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.